Ligand Pharmaceuticals
LGND
#2821
Rank
A$8.99 B
Marketcap
A$414.60
Share price
-2.33%
Change (1 day)
80.38%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2026 (TTM): A$0.28 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are A$0.27 Billion. In 2025 the company made an earning of A$0.23 Billion, an increase over its 2024 earnings that were of A$7.85 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.28 B24.67%
2025 A$0.23 B2848.57%
2024 A$7.85 M-91.37%
2023 A$90.96 M-7.59%
2022 A$98.43 M4%
2021 A$94.64 M296.42%
2020 A$23.87 M-97.97%
2019 A$1.17 B275.62%
2018 A$0.31 B237.48%
2017 A$92.86 M49.05%
2016 A$62.3 M55.41%
2015 A$40.09 M36.87%
2014 A$29.29 M29.59%
2013 A$22.6 M1309.35%
2012 A$1.6 M-43.97%
2011 A$2.86 M-113.19%
2010 -A$21.71 Million59.86%
2009 -A$13.58 Million-61.33%
2008 -A$35.11 Million-58.75%
2007 -A$85.11 Million20.52%
2006 -A$70.62 Million81.27%
2005 -A$38.96 Million
2003 -A$27.13 Million-20.6%
2002 -A$34.16 Million4.38%
2001 -A$32.73 Million-48.83%
2000 -A$63.95 Million-19.74%
1999 -A$79.68 Million-19.06%
1998 -A$98.44 Million126.71%
1997 -A$43.42 Million-5.83%
1996 -A$46.11 Million136.23%
1995 -A$19.52 Million-33.97%
1994 -A$29.56 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$36.74 B 13,538.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$14.97 B 5,460.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$44.02 B 16,240.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$12.85 B 4,670.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-A$0.72 Billion-366.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$18.60 B 6,804.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$13.57 B 4,938.43%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$14.15 B 5,155.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-A$87.52 Million-132.49%๐Ÿ‡บ๐Ÿ‡ธ USA